Tafamidis
Tafamidis

Tafamidis

Catalog NumberPI594839880

CAS Number594839-88-0

CategoryCardiovascular Drugs

Tafamidis free acid form is a non-nonsteroidal anti-inflammatory benzoxazole derivative. Tafamidis, sold under the brand name Vyndamax among others, was developed by FoldRX, now acquired by Pfizer. It was approved by FDA in 2019.
Tafamidis

* Our products are for research use only.

Get in Touch

We're glad to help you with your products and services demands. For any inquiry, question or recommendation, please send an email to or fill out the following form.

For product and service inquiries icon1

For product and service inquiries, please use our online system or send an email to .

For product and service inquiries icon2